4.4 Review

Neuropathic pain and its assessment

Journal

SURGICAL ONCOLOGY-OXFORD
Volume 19, Issue 3, Pages 149-154

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.suronc.2009.11.012

Keywords

Nociceptive fibres; Neuropathic pain; Laser evoked potentials; Skin biopsy

Ask authors/readers for more resources

Neuropathic pain, i.e., pain arising as a direct consequence of a lesion or disease affecting the somatosensory system, is a frequent complaint in the elderly. The frequency of herpes zoster and peripheral neuropathy, the commonest diseases that cause neuropathic pain, increases with age. More than half of all persons in whom herpes zoster develops are older than 60 years and about 30% of these patients will ultimately suffer from chronic postherpetic neuralgia. The prevalence of peripheral neuropathy rises from 2.4% in the general population to 8% in subjects older than 55 years. With advancing age, the nociceptive pathway undergoes degenerative changes, mainly consisting of axonal loss. This age-related nociceptive pathway degeneration probably explains why elderly patients tend to under-report pain in many medical conditions including myocardial infarction, fractures, and arthritis. This age-related impairment probably plays a key role in the development of neuropathic pain. In this report we describe the most reliable methods for assessing neuropathic pain such as laser evoked potential (LEP) recordings and skin biopsy, procedures that selectively assess nociceptive pathways in order to obtain a rapid diagnosis and hence determine treatment. (C) 2009 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available